Parkinson’s Disease

Clinical Study

Benefit from the Chin-Down Maneuver in the Swallowing Performance and Self-Perception of Parkinson’s Disease Patients

Table 1

Sociodemographic and clinical data.


Groups	Experimental (EG)	Control (CG)	Orientation (OG)	value
Groups				value

Male gender	80%	75%	66.70%	—
	62.0 (±11.5)	62.8 (±6.2)	64.5 (±5.6)
	5.9 (±4.1)	10.3 (±8.4)	12.0 (±9.1)
Time of	10.7 (±4.7)	11.8 (±8.0)	8.8 (±6.0)
	2.8 (±0.8)	2.5 (±0.7)	2.5 (±0.8)
	26.6 (±3.8)	25.6 (±3.7)	25.3 (±4.1)
	21.9 (±4.9)	20.5 (±7.7)	21.2 (±8.4)
	41.4 (±13.8)	38.7 (±16.7)	36.5 (±17.1)
	13.8 (±7.7)	17.1 (±9.2)	14.7 (±9.3)
	5.9 (±1.3)	6.8 (±0.5)	6.8 (±0.4)	—

ANOVA; Kruskal-Wallis test; Representation of the data as mean and standard deviation; H&Y: Hoehn & Yahr Scale; MMSE: Mini-Mental State Examination; MOCA: Montreal Cognitive Assessment; PDQ-39: Parkinson’s Disease Questionnaire-39; BDI: Beck Depression Inventory; FOIS: Functional Oral Intake Scale. — indicates that statistical testing was not applied to this variable (FOIS).